{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:31:55Z","timestamp":1794886315637,"version":"4.9.1"},"reference-count":39,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,12,30]],"date-time":"2008-12-30T00:00:00Z","timestamp":1230595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\n\t\t\t\t\t<\/jats:bold> The role of probiotics in allergy prevention remains uncertain but has been shown in some studies to have a possible protective effect on eczema.<\/jats:p><jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> We aimed to assess the effect of probiotic supplementation in the first 6 months of life on eczema and allergic sensitization at 1 year of age in Asian infants at risk of allergic disease.<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> A double\u2010blind, placebo\u2010controlled randomized clinical trial involving 253 infants with a family history of allergic disease was carried out. Infants received at least 60\u2003mL of commercially available cow's milk formula with or without probiotic supplementation [<jats:italic>Bifidobacterium longum<\/jats:italic> (BL999) 1 \u00d7 10<jats:sup>7<\/jats:sup>\u2003colony forming unit (CFU)\/g and <jats:italic>Lactobacillus rhamnosus<\/jats:italic> (LPR) 2 \u00d7 10<jats:sup>7<\/jats:sup>\u2003CFU\/g] daily for the first 6 months. Clinical evaluation was performed at 1, 3, 6 and 12 months of age, with serum total IgE measurement and skin prick tests conducted at the 12\u2010month visit. The primary and secondary end\u2010points were eczema and allergen sensitization, respectively.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> The incidence of eczema in the probiotic (22%) group was similar to that in the placebo group (25%) (<jats:italic>P<\/jats:italic>=0.53). The median Scoring Atopic Dermatitis score at 12 months was 17.10 (9.74) in the probiotic group and 11.60 (8.40) in the placebo group (<jats:italic>P<\/jats:italic>=0.17). The prevalence of allergen sensitization showed no difference (probiotic=24% vs. placebo=19%, <jats:italic>P<\/jats:italic>=0.26). The total IgE geometric mean (95% confidence interval) was 18.76 (12.54\u201324.98)\u2003kU\/L in the probiotic group and 23.13 (16.01\u201330.24)\u2003kU\/L in the placebo group (<jats:italic>P<\/jats:italic>=0.15). Atopic eczema (with sensitization) in the probiotic (7.3%) group was comparable to the placebo group (5.8%) (<jats:italic>P<\/jats:italic>=0.86).<\/jats:p><jats:p><jats:bold>Conclusion\n\t\t\t\t\t<\/jats:bold> Early life administration of a cow's milk formula supplemented with probiotics showed no effect on prevention of eczema or allergen sensitization in the first year of life in Asian infants at risk of allergic disease. Further work is needed to determine whether timing of supplementation, dose and probiotic strain are important considerations.<\/jats:p>","DOI":"10.1111\/j.1365-2222.2008.03133.x","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T21:13:06Z","timestamp":1230757986000},"page":"571-578","source":"Crossref","is-referenced-by-count":148,"title":["Probiotic supplementation in the first 6 months of life in at risk Asian infants \u2013 effects on eczema and atopic sensitization at the age of 1 year"],"prefix":"10.1111","volume":"39","author":[{"given":"S. E.","family":"Soh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Gerez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. S.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rauff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. P. M.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. B.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. P.\u2010C.","family":"Shek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,12]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"465S","DOI":"10.1093\/ajcn\/73.2.465s","article-title":"Probiotics and safety","volume":"73","author":"Ishibashi N","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/368080"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.118130"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.6.3237"},{"key":"e_1_2_6_6_2","first-page":"165","article-title":"Immunomodulatory effects of probiotic bacteria DNA","volume":"38","author":"Lammers KM","year":"2003","journal-title":"IL-1 and IL-10 response in human peripheral blood mononuclear cells"},{"key":"e_1_2_6_7_2","first-page":"1174","article-title":"Probiotics in prevention of IgE\u2010associated eczema","volume":"119","author":"Abrahamsson TR","year":"2007","journal-title":"a double-blind, randomized, placebo-controlled trial"},{"key":"e_1_2_6_8_2","first-page":"899","article-title":"No effects of probiotics on atopic dermatitis in infancy","volume":"36","author":"Brouwer ML","year":"2006","journal-title":"a randomized placebo-controlled trial"},{"key":"e_1_2_6_9_2","first-page":"1076","article-title":"Probiotics in primary prevention of atopic disease","volume":"357","author":"Kalliom\u00e4ki M","year":"2001","journal-title":"a randomised placebo-controlled trial"},{"key":"e_1_2_6_10_2","first-page":"1869","article-title":"Probiotics and prevention of atopic disease","volume":"361","author":"Kalliom\u00e4ki M","year":"2003","journal-title":"4-year follow-up of a randomised placebo-controlled trial"},{"key":"e_1_2_6_11_2","first-page":"1019","article-title":"Probiotics during the first 7 years of life","volume":"119","author":"Kalliom\u00e4ki M","year":"2007","journal-title":"a cumulative risk reduction of eczema in a randomized, placebo-controlled trial"},{"key":"e_1_2_6_12_2","first-page":"192","article-title":"Probiotics and prebiotic galacto\u2010oligosaccharides in the prevention of allergic diseases","volume":"119","author":"Kukkonen K","year":"2007","journal-title":"a randomized, double-blind, placebo-controlled trial"},{"key":"e_1_2_6_13_2","first-page":"184","article-title":"Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high\u2010risk children","volume":"119","author":"Taylor AL","year":"2007","journal-title":"a randomized controlled trial"},{"key":"e_1_2_6_14_2","first-page":"494","article-title":"Probiotics in the treatment of atopic eczema\/dermatitis syndrome in infants","volume":"60","author":"Viljanen M","year":"2005","journal-title":"a double-blind placebo-controlled trial"},{"key":"e_1_2_6_15_2","first-page":"CD006475","article-title":"Probiotics in infants for prevention of allergic disease and food hypersensitivity","author":"Osborn DA","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.10.043"},{"key":"e_1_2_6_17_2","first-page":"e850","article-title":"Randomized, double\u2010blind, placebo\u2010controlled trial of probiotics for primary prevention","volume":"121","author":"Kopp MV","year":"2008","journal-title":"no clinical effects of Lactobacillus GG supplementation"},{"key":"e_1_2_6_18_2","volume-title":"Sample size tables for clinical studies","author":"Machin DCM","year":"1997"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.1999.00050.x"},{"key":"e_1_2_6_20_2","unstructured":"Joint FAO\/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including milk powder with live lactic acid bacteria. FAO\/WHO (Food and Agriculture Organization\/World Health Organization) 2001."},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70288-6"},{"key":"e_1_2_6_22_2","first-page":"23","article-title":"Severity scoring of atopic dermatitis","volume":"186","year":"1993","journal-title":"the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.2174\/187152806779010954"},{"issue":"14","key":"e_1_2_6_24_2","first-page":"48","article-title":"Position paper","volume":"48","year":"1993","journal-title":"allergen standardization and skin tests. The European Academy of Allergology and Clinical Immunology"},{"key":"e_1_2_6_25_2","volume-title":"CLINTRIAL\u2122 4 release 4.2 reference guide","author":"Domain Pharma Corporation","year":"1999"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpg.0000189346.25172.fd"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2007.00687.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2008.02080.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2006.03111.x"},{"key":"e_1_2_6_30_2","first-page":"1425","article-title":"Probiotics in the treatment of Japanese cedar pollinosis","volume":"36","author":"Xiao JZ","year":"2006","journal-title":"a double-blind placebo-controlled trial"},{"key":"e_1_2_6_31_2","first-page":"86","article-title":"Effect of probiotic Bifidobacterium longum BB536 [corrected] in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized double\u2010blind, placebo\u2010controlled trial","volume":"16","author":"Xiao JZ","year":"2006","journal-title":"J Invest Allergol Clin Immunol"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/87.5.1365"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2006.098251"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31802fca8c"},{"key":"e_1_2_6_35_2","first-page":"CD006474","article-title":"Prebiotics in infants for prevention of allergic disease and food hypersensitivity","author":"Osborn DA","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e31815991d5"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.WOX.0000301676.55647.50"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/heapro\/dai002"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1754.2002.00725.x"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.11.004"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.2008.03133.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.2008.03133.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T18:12:58Z","timestamp":1695924778000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.2008.03133.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,12]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1111\/j.1365-2222.2008.03133.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.2008.03133.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,12]]}}}